nuclear energy

NuScale offers higher growth potential as the only approved SMR designer but faces years before revenue. Constellation Energy provides profitable operations, Microsoft/Meta contracts, and a growing dividend—making it the more prudent choice.

NuScale Power trades below $12 as a pre-commercial nuclear technology firm with $31.5M revenue but no operational reactors, betting on a $2.2T sector opportunity.

Cameco positioned as key uranium supplier amid U.S. nuclear expansion plans, with 39% projected annual EPS growth through 2028 despite recent valuation concerns.

Fluor expands nuclear presence in Europe, managing major projects including NuScale's small modular reactors and Cernavodã plant upgrades amid global energy transition.

Oil hits $119 amid Middle East tensions, driving investors toward nuclear power. Cameco emerges as key uranium supplier beneficiary with Asian contracts and Westinghouse stake.

NuScale Power stock has corrected 40% to $4B valuation, offering growth potential from AI's electricity demands but facing execution risks and intense competition.

NextEra Energy leverages nuclear partnerships and 32-year dividend growth to capitalize on global atomic energy resurgence, targeting 8% EPS growth through 2035.

SoftBank's $6.3B power plant fee slashed 90% by Tokyo officials amid $550B U.S.-Japan trade deal concerns. Company retains 15-20 year conditional payments, maintains $10B turbine order.

Four energy stocks offer compelling dividend yields: pipeline operators Oneok and Kinder Morgan for stable cash flow, Chevron for 39-year dividend growth, Constellation Energy for nuclear/AI demand.

Oklo stock jumped 10% after securing DOE and NRC approvals for its Aurora reactor and nuclear fuel recycling operations, with analysts targeting 130% upside.

Oklo receives inaugural NRC materials license for Atomic Alchemy subsidiary, enabling Idaho isotope processing. Stock rallies 4.5% on commercialization milestone.

3M and Cameco offer portfolio diversification against potential AI bubble risks, combining industrial recovery and nuclear energy demand growth as hedges to technology-heavy portfolios.

Radnostix terminates $12.45M asset sale with American Fuel Resources, retains DUF6 plant assets amid nuclear energy sector revival.

Oklo and Centrus Energy partner on HALEU fuel production. Centrus rated superior due to profitable operations; Oklo years from commercialization despite Meta deal.

Cameco, BWX Technologies, and Constellation Energy position investors for nuclear energy growth amid rising global electricity demand and decarbonization efforts.

AI data centers spark nuclear interest as NuScale and Oklo pursue small modular reactors. $2.2 trillion market opportunity faces significant technology and regulatory risks.

Oklo stock surged 160% but fell 65% from peaks, despite zero revenue and $9.7B valuation. Meta deal looks promising, but regulatory delays and execution risks make it a risky bet.

Oklo positioned as better bet for AI data centers with smaller reactors despite $9.8B valuation versus NuScale's $3.9B market cap.

Palantir and Centrus Energy partner to deploy AI software for uranium enrichment operations, identifying $300 million in potential cost savings.

NuScale stock plunged 79% to $12 despite NRC certification, facing execution risks and $6B in contingent partnership obligations before generating material revenue.